pioglitazone has been researched along with Carcinoma 256, Walker in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cachexia is a multifactorial syndrome characterized by profound involuntary weight loss, fat depletion, skeletal muscle wasting, and asthenia; all symptoms are not entirely attributable to inadequate nutritional intake." | 5.42 | Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. ( Andreotti, S; Batista, ML; Beluzi, M; Farmer, SR; Franco, FO; Henriques, FS; Knobl, P; Lima, FB; Neves, RX; Peres, SB; Santos, KB; Seelaender, M; Sertié, RA; Shida, CS, 2015) |
| "Cachexia is a multifactorial syndrome characterized by profound involuntary weight loss, fat depletion, skeletal muscle wasting, and asthenia; all symptoms are not entirely attributable to inadequate nutritional intake." | 1.42 | Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. ( Andreotti, S; Batista, ML; Beluzi, M; Farmer, SR; Franco, FO; Henriques, FS; Knobl, P; Lima, FB; Neves, RX; Peres, SB; Santos, KB; Seelaender, M; Sertié, RA; Shida, CS, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beluzi, M | 1 |
| Peres, SB | 1 |
| Henriques, FS | 1 |
| Sertié, RA | 1 |
| Franco, FO | 1 |
| Santos, KB | 1 |
| Knobl, P | 1 |
| Andreotti, S | 1 |
| Shida, CS | 1 |
| Neves, RX | 1 |
| Farmer, SR | 1 |
| Seelaender, M | 1 |
| Lima, FB | 1 |
| Batista, ML | 1 |
1 other study available for pioglitazone and Carcinoma 256, Walker
| Article | Year |
|---|---|
Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.
Topics: Adiponectin; Adipose Tissue; Animals; Body Weight; Cachexia; Carcinoma 256, Walker; CCAAT-Enhancer-B | 2015 |